Chronic Granulomatous Disease Market: Global Industry Analysis and Forecast (2023-2029)

Chronic Granulomatous Disease Market size was valued at US$ 1.16 Bn. in 2022 and the total revenue is expected to grow at a CAGR of 4.20% through 2022 to 2029, reaching nearly US$ 1.54 Bn.
Chronic Granulomatous Disease Market Overview:

Chronic granulomatous disease (CGD) is a hereditary illness in which phagocytes, which are white blood cells, are unable to eliminate certain bacteria and fungi. People with CGD are more prone to bacterial and fungal infections, which can be life-threatening. X-Linked Chronic Granulomatous Disease, and Autosomal Recessive Chronic Granulomatous Disease are the types of the Chronic Granulomatous Disease. Infection Management, Trimethoprim, Sulfamethoxazole, Itraconazole, Interferon-gamma, and Stem cell transplantation are some of the types of the treatments of the chronic granulomatous disease (CGD).